Study Looking at a Drug to Treat Myelodysplastic Syndrome

What we are studying

The purpose of this study is to test the safety and effectiveness of an investigational drug called when used to treat myelodysplastic syndrome (MDS).

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with MDS (myelodysplastic syndrome)that has failed with previous therapies

What is involved

  • You will be give the investigational drug 2 times each week for 3 weeks followed by a week of rest (a cycle). All participants will be in the study for at least 2 months.

Compensation

None

Contact Information

Study Coordinator
Robin Harrelson
Email
rharrels@wakehealth.edu
Phone
336-713-6924

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.